These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11007104)

  • 1. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.
    Dhiman RK; Sawhney MS; Chawla YK; Das G; Ram S; Dilawari JB
    Dig Dis Sci; 2000 Aug; 45(8):1549-52. PubMed ID: 11007104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
    Watanabe A; Sakai T; Sato S; Imai F; Ohto M; Arakawa Y; Toda G; Kobayashi K; Muto Y; Tsujii T; Kawasaki H; Okita K; Tanikawa K; Fujiyama S; Shimada S
    Hepatology; 1997 Dec; 26(6):1410-4. PubMed ID: 9397979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.
    Das A; Dhiman RK; Saraswat VA; Verma M; Naik SR
    J Gastroenterol Hepatol; 2001 May; 16(5):531-5. PubMed ID: 11350549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY; Alonso M; Stanger LC
    J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy].
    Nie YQ; Zeng Z; Li YY; Sha WH; Ping L; Dai SJ
    Zhonghua Nei Ke Za Zhi; 2003 Apr; 42(4):261-3. PubMed ID: 12887812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.
    Horsmans Y; Solbreux PM; Daenens C; Desager JP; Geubel AP
    Aliment Pharmacol Ther; 1997 Feb; 11(1):165-70. PubMed ID: 9042989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
    Shen YC; Chang YH; Fang CJ; Lin YS
    Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
    Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
    Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China.
    Li YY; Nie YQ; Sha WH; Zeng Z; Yang FY; Ping L; Jia L
    World J Gastroenterol; 2004 Aug; 10(16):2397-401. PubMed ID: 15285027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
    Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
    J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.